Co-translational determination of quaternary structures in chaperone factories

Read full text
Authors: Manon Philippe, Soha Salloum, Floric Slimani, Davide Normanno, Isabelle Barbosa, Héloïse Chassé, Marie-Cécile Robert, Serge Urbach, Jacques Imbert, Martial Sevéno, Simon J. George, Hervé Le Hir
+3 more Séverine Boulon, Céline Verheggen, Édouard Bertrand
Cited by: 2
References: 78

Abstract

The HSP90/R2TP quaternary chaperone assembles key cellular machines, including the three nuclear RNA polymerases and many non-coding RNPs. Here, we characterize the RNAs associated with R2TP and find that it binds many proteins co-translationally. Its co-translational interactome reveals potential clients and distinguishes clients bound only co-translationally, only post-translationally, or both. For subunits assembling together in the same complex and bound co-translationally by R2TP, only a marginal proportion of their mRNAs is co-localized and co-translated. Instead, HSP90 and R2TP induce the formation of polysome condensates accumulating these chaperones and specific client mRNAs, thus favoring co-translational interactions between them. During the assembly process, R2TP cycles between co- and post-translational steps and this is regulated by ATP: it binds co-translationally in absence of ATP and becomes released from post-translational assembly intermediates by ATP hydrolysis. This co-translational mechanism, named co-translational chaperone channeling (cha-cha), substitutes for the rarity of co-localized/co-translated mRNAs. In turn, chaperones have the remarkable ability to spatially organize the translational apparatus in the cytoplasm. The HSP90/R2TP chaperone assembles key cellular machines such as RNA polymerases or non-coding RNPs. Here, the authors show that R2TP binds co-translationally to many of its clients. It also contributes to the formation of specific polysome condensates that concentrate together R2TP and its clients.

Fields of Study & Subjects

Heat shock proteins research Nuclear Structure and Function PARP inhibition in cancer therapy

Publication details

Journal / source
Nature Communications
Publisher
Springer Science and Business Media LLC
Volume
17
Issue
1
Publication date
23 January 2026
Language
EN